(R)-tert-Butyl 3-(2-amino-3-fluorophenoxy)pyrrolidine-1-carboxylate, 95.0%, 1g

2-[(6-Oxido-6H-dibenzo[c,e][1,2]oxaphosphinin-6-yl)methyl]succinic Acid>98.0%(HPLC)(T)1g

N-Benzyl-2-bromoacetamide, 95.0%, 250mg

7-FLUOROQUINOLINE-3-CARBOXYLIC ACID, 95.0%, 100mg

3-Fluoro-4-methyl-2-(methylthio)phenylboronic acid, 95%, 500mg

3-ethyl-1,2,4-oxadiazol-5-amine, 95.0%, 250mg

(5-Chloromethyl-[1,2,4]oxadiazol-3-yl)-acetic acid ethyl ester, 95.0%, 1g

1-Pyrrolidin-3-(2'-chlorophenyl)-3-(N-Cbz-N-methyl)amino-propane, 97.0%, 250mg

(R)-2-Phenylpropan-1-ol, 97%, 1g

4-hydroxybenzoate de méthyle, min.98%, Ph.Eur., 500 g, emballage plastique.

D-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester, hydrochloride (1:1), 97%, 10g

4-(Aminomethyl)-3-fluorophenol hydrochloride, 97%, 100mg

Cinnamyl formate, 95.0%, 500g